Clinical factors associated with BRCA1 pathogenic variants included a family history of breast cancer and hormone receptor status of the tumor, while for BRCA2, the only statistically significant clinical factor was a family history of breast cancer. The gene discussed is NR4A1; the disease is neoplasm.